Checkmate Capital logo

Checkmate Capital

North America, California, United States, Pasadena

Description

Checkmate Capital is an investment and transaction advisory group with a global investor network that manages family office assets.

Investor Profile

Checkmate Capital has made 5 investments, with 0 in the past 12 months and 80% as lead.

Stage Focus

  • Seed (40%)
  • Convertible Note (20%)
  • Pre Seed (20%)
  • Series A (20%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Oncology
  • Therapeutics
  • Pharmaceutical
  • Analytics
  • Medical Device
  • Precision Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Checkmate Capital frequently co-invest with?

Global Health Impact Fund
North America, California, United States, Walnut Creek
Co-Investments: 1
Sand Hill Angels
North America, California, United States, Mountain View
Co-Investments: 1
IAG Capital Partners
North America, South Carolina, United States, Charleston
Co-Investments: 1
MedTex Ventures
North America, Connecticut, United States, Norwalk
Co-Investments: 1
BF
Europe, Cluj, Romania, Cluj-napoca
Co-Investments: 1
MI
North America, Illinois, United States, Chicago
Co-Investments: 1
1517 Fund
North America, California, United States, Oakland
Co-Investments: 1
Bioverge
North America, California, United States, San Francisco
Co-Investments: 1
AP
North America, Ohio, United States, Cincinnati
Co-Investments: 1
BlueStone Venture Partners
North America, Arizona, United States, Tucson
Co-Investments: 1

Which angels does Checkmate Capital often collaborate with?

JG
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Checkmate Capital?

Lynx Biosciences

San Diego, California, United States

Lynx Biosciencesis a clinical-stage biotechnology company.

BiotechnologyHealth Care
SeedNov 3, 2021
MAIA Biotechnology

Chicago, Illinois, United States

MAIA Biotechnology is an immuno-oncology company that focuses on developing first-in-class drugs with novel mechanisms.

BiotechnologyHealth CareOncologyTherapeutics
Convertible NoteMay 19, 2021
Amount Raised: $8,000,000
Elucid

Boston, Massachusetts, United States

Elucid enables precision medicine for cardiovascular disease by applying A.I to medical image analysis validated against true biology.

AnalyticsBiotechnologyMedical DevicePrecision Medicine
Series AMay 10, 2021
Amount Raised: $10,000,000
Lactiga

Princeton, New Jersey, United States

Lactiga is a biotherapeutics company advancing its patented biologics to transform the anti-infective sector and protect vulnerable patients

BiotechnologyPharmaceutical
Pre SeedDec 1, 2020
Amount Raised: $1,400,000
Monarch Biosciences

Los Angeles, California, United States

Monarch Biosciences is commercializing the next generation of cell therapy and regenerative medicine products.

BiotechnologyHealth Care
SeedApr 8, 2020
Amount Raised: $1,000,000